These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 29030990)
1. Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. Barbarisi M; Iaffaioli RV; Armenia E; Schiavo L; De Sena G; Tafuto S; Barbarisi A; Quagliariello V J Cell Physiol; 2018 Oct; 233(10):6550-6564. PubMed ID: 29030990 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer. Quagliariello V; Iaffaioli RV; Armenia E; Clemente O; Barbarisi M; Nasti G; Berretta M; Ottaiano A; Barbarisi A J Cell Physiol; 2017 Aug; 232(8):2063-2074. PubMed ID: 27607841 [TBL] [Abstract][Full Text] [Related]
3. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies. Fadera S; Chen PY; Liu HL; Lee IC ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925 [TBL] [Abstract][Full Text] [Related]
4. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689 [TBL] [Abstract][Full Text] [Related]
5. Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma. Xiao W; Wang S; Zhang R; Sohrabi A; Yu Q; Liu S; Ehsanipour A; Liang J; Bierman RD; Nathanson DA; Seidlits SK Matrix Biol; 2020 Jan; 85-86():128-146. PubMed ID: 31028838 [TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma. Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307 [TBL] [Abstract][Full Text] [Related]
7. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Hayward SL; Wilson CL; Kidambi S Oncotarget; 2016 Jun; 7(23):34158-71. PubMed ID: 27120809 [TBL] [Abstract][Full Text] [Related]
9. New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase. Quagliariello V; Armenia E; Aurilio C; Rosso F; Clemente O; de Sena G; Barbarisi M; Barbarisi A J Cell Physiol; 2016 Aug; 231(8):1784-95. PubMed ID: 26660542 [TBL] [Abstract][Full Text] [Related]
10. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181 [TBL] [Abstract][Full Text] [Related]
11. Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations. Zafar S; Negi LM; Verma AK; Kumar V; Tyagi A; Singh P; Iqbal Z; Talegaonkar S Int J Pharm; 2014 Dec; 477(1-2):454-68. PubMed ID: 25445525 [TBL] [Abstract][Full Text] [Related]
12. Quercetin-loaded platelets as a potential targeted therapy for glioblastoma multiforme cell line U373-MG. Bhandarkar S; Prabhakar B; Shende P Biotechnol J; 2021 Dec; 16(12):e2100271. PubMed ID: 34562072 [TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532 [TBL] [Abstract][Full Text] [Related]
14. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Kim Y; Kumar S Mol Cancer Res; 2014 Oct; 12(10):1416-29. PubMed ID: 24962319 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study. Serri C; Quagliariello V; Iaffaioli RV; Fusco S; Botti G; Mayol L; Biondi M J Cell Physiol; 2019 Apr; 234(4):4959-4969. PubMed ID: 30334571 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid-Modified Micelles Encapsulating Gem-C Liu X; Li W; Chen T; Yang Q; Huang T; Fu Y; Gong T; Zhang Z Mol Pharm; 2018 Mar; 15(3):1203-1214. PubMed ID: 29397747 [TBL] [Abstract][Full Text] [Related]
18. Fabrication and Characterization of Chitosan-Hyaluronic Acid Scaffolds with Varying Stiffness for Glioblastoma Cell Culture. Erickson AE; Lan Levengood SK; Sun J; Chang FC; Zhang M Adv Healthc Mater; 2018 Aug; 7(15):e1800295. PubMed ID: 29893067 [TBL] [Abstract][Full Text] [Related]
19. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562 [TBL] [Abstract][Full Text] [Related]
20. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]